Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Shattuck Labs (STTK) Cash & Equivalents (2019 - 2025)

Shattuck Labs (STTK) has disclosed Cash & Equivalents for 7 consecutive years, with $54.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 5.57% to $54.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $54.2 million, a 5.57% decrease, with the full-year FY2025 number at $54.2 million, down 5.57% from a year prior.
  • Cash & Equivalents was $54.2 million for Q4 2025 at Shattuck Labs, up from $42.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $125.6 million in Q4 2023 to a low of $37.9 million in Q2 2022.
  • A 5-year average of $63.7 million and a median of $59.0 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 56.22% in 2022, then surged 165.15% in 2023.
  • Shattuck Labs' Cash & Equivalents stood at $92.3 million in 2021, then crashed by 48.65% to $47.4 million in 2022, then soared by 165.15% to $125.6 million in 2023, then plummeted by 54.32% to $57.4 million in 2024, then fell by 5.57% to $54.2 million in 2025.
  • Per Business Quant, the three most recent readings for STTK's Cash & Equivalents are $54.2 million (Q4 2025), $42.5 million (Q3 2025), and $50.5 million (Q2 2025).